Adrenocortical Carcinoma Clinical Trials
3 recruiting trials for Adrenocortical Carcinoma. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 1NCT04119024
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic...
This phase I trial studies the side effects and best dose of modified immune cells (IL13Ralpha2 CAR T cells) after a chemotherapy conditioning regimen for the treatment of...
Sponsor: Anusha KalbasiEnrolling: 183 locations
RECRUITINGNCT03050268
Familial Investigations of Childhood Cancer Predisposition
NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may receive results many...
Sponsor: St. Jude Children's Research HospitalEnrolling: 15001 location
RECRUITINGPhase 2NCT06066333
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
The purpose of this study is to determine whether pembrolizumab given after standard ablative Radiotherapy is a safe treatment that causes few or mild side effects in people with...
Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 127 locations